Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Disrupting Acvr1b in mice causes severe hair loss and thicker skin.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

LONRF1 is important for oxidative damage response and tissue remodeling during wound healing.

JAK inhibitors like baricitinib and ritlecitinib are effective new treatments for severe alopecia areata.

Certain genes in Iranian sheep are linked to wool production and heat adaptation.

Scientists created a cell model to study and find treatments for a skin disease called RDEB.

Krt15+ cells in the mouse intestine resist radiation and can start tumors.

GPRC5D is linked to the formation of hair, nails, and certain tongue areas.

A mutation in the IL2RA gene increases the risk of alopecia areata.

Only one K16 gene on chromosome 17 makes a functional keratin protein.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

Removing certain immune cells in mice causes their hair to enter the growth phase earlier than usual.

aPKCλ is essential for hair follicle stem cell maintenance and wound healing.

AP-1 controls tumor cell type by affecting key signaling pathways.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

RNase L hinders hair follicle regeneration by altering immune signals.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Involucrin is a useful marker for keratinocyte differentiation in mice.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

The LEF-1 binding site enhances gene expression in hair follicles, with other proteins aiding specific regulation.